Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2001 2
2003 1
2008 1
2009 1
2010 1
2011 1
2012 2
2014 3
2015 2
2016 1
2017 1
2018 1
2019 1
2021 1
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Acute episodes of neuropathic symptoms"
Page 1
Lithium treatment of Bipolar disorder in adults: A systematic review of randomized trials and meta-analyses.
Fountoulakis KN, Tohen M, Zarate CA Jr. Fountoulakis KN, et al. Eur Neuropsychopharmacol. 2022 Jan;54:100-115. doi: 10.1016/j.euroneuro.2021.10.003. Eur Neuropsychopharmacol. 2022. PMID: 34980362 Free PMC article. Review.
The aim of the study was to systematically review the hard evidence alone, concerning lithium efficacy separately for the phases and clinical facets of Bipolar disorder (BD). The PRISMA method was followed to search the MEDLINE for Randomized Controlled trials, Post …
The aim of the study was to systematically review the hard evidence alone, concerning lithium efficacy separately for the phases and clin …
Intravenous lacosamide and phenytoin for the treatment of acute exacerbations of trigeminal neuralgia: A retrospective analysis of 144 cases.
Muñoz-Vendrell A, Teixidor S, Sala-Padró J, Campoy S, Huerta-Villanueva M. Muñoz-Vendrell A, et al. Cephalalgia. 2022 Sep;42(10):1031-1038. doi: 10.1177/03331024221092435. Epub 2022 Apr 26. Cephalalgia. 2022. PMID: 35469475 Free PMC article. Review.
BACKGROUND: Scant evidence is available on the use of intravenous pain treatment in acute exacerbations of trigeminal neuralgia. The aim of this descriptive study was to evaluate the effectiveness and security of intravenous lacosamide and phenytoin in the treatment of …
BACKGROUND: Scant evidence is available on the use of intravenous pain treatment in acute exacerbations of trigeminal neuralgia. The …
Treatment for idiopathic and hereditary neuralgic amyotrophy (brachial neuritis).
van Alfen N, van Engelen BG, Hughes RA. van Alfen N, et al. Cochrane Database Syst Rev. 2009 Jul 8;2009(3):CD006976. doi: 10.1002/14651858.CD006976.pub2. Cochrane Database Syst Rev. 2009. PMID: 19588414 Free PMC article. Review.
Neuralgic amyotrophy has both an idiopathic and hereditary form, with similar clinical symptoms but generally an earlier age of onset and more episodes in the hereditary form. ...SELECTION CRITERIA: Any randomised or quasi-randomised trial …
Neuralgic amyotrophy has both an idiopathic and hereditary form, with similar clinical symptoms but generally an earlier age o …
Characterization of pain in fabry disease.
Üçeyler N, Ganendiran S, Kramer D, Sommer C. Üçeyler N, et al. Clin J Pain. 2014 Oct;30(10):915-20. doi: 10.1097/AJP.0000000000000041. Clin J Pain. 2014. PMID: 24121530
Fabry pain is triggerable by physical activity and thermal stimuli and improves over time. Frequently used acute pain medication consists of nonsteroidal antirheumatics and nonopioid analgesics. ...Current pain questionnaires fail to cover the entire scope of Fabry pain. A …
Fabry pain is triggerable by physical activity and thermal stimuli and improves over time. Frequently used acute pain medication cons …
Multimodal Analgesic Plan for Children Undergoing Chimeric 14.18 Immunotherapy.
Bertolizio G, Otis A, Tam K, Aswar S, Garbin M, Ingelmo P. Bertolizio G, et al. J Pediatr Hematol Oncol. 2021 Mar 1;43(2):e169-e172. doi: 10.1097/MPH.0000000000001722. J Pediatr Hematol Oncol. 2021. PMID: 31972721
Immunotherapy with the chimeric 14.18 anti-GD2 antibody (ch14.18) is associated with severe neuropathic pain. Different analgesic modalities have been employed, but pain management remains challenging and side effects such as desaturation, bradycardia, and hypotension have …
Immunotherapy with the chimeric 14.18 anti-GD2 antibody (ch14.18) is associated with severe neuropathic pain. Different analgesic mod …
One-year follow-up of patients with long-lasting post-herpetic neuralgia.
Pica F, Gatti A, Divizia M, Lazzari M, Ciotti M, Sabato AF, Volpi A. Pica F, et al. BMC Infect Dis. 2014 Nov 1;14:556. doi: 10.1186/s12879-014-0556-6. BMC Infect Dis. 2014. PMID: 25361823 Free PMC article.
METHODS: This study was conducted at the Pain Clinic of the Policlinico Tor Vergata, Rome, Italy, on eighty-five immunocompetent patients with a clinical diagnosis of PHN. At enrollment (time 0, T0), the patients were interviewed by physicians to obtain demographic …
METHODS: This study was conducted at the Pain Clinic of the Policlinico Tor Vergata, Rome, Italy, on eighty-five immunocompetent patients wi …
Neuropathic pain during treatment for childhood acute lymphoblastic leukemia.
Anghelescu DL, Faughnan LG, Jeha S, Relling MV, Hinds PS, Sandlund JT, Cheng C, Pei D, Hankins G, Pauley JL, Pui CH. Anghelescu DL, et al. Pediatr Blood Cancer. 2011 Dec 15;57(7):1147-53. doi: 10.1002/pbc.23039. Epub 2011 Feb 11. Pediatr Blood Cancer. 2011. PMID: 21319291 Free PMC article.
One hundred and seventy-four of 498 patients (34.9%) experienced 207 episodes of NP; 16% (28 of 174) patients experienced at least one recurrence of pain after the initial episode. ...The selection of treatment with gabapentin or opioids was not influenced by the pa …
One hundred and seventy-four of 498 patients (34.9%) experienced 207 episodes of NP; 16% (28 of 174) patients experienced at least on …
Impact of noncancer pain on health-related quality of life.
Lapane KL, Quilliam BJ, Benson C, Chow W, Kim MS. Lapane KL, et al. Pain Pract. 2015 Apr;15(4):333-42. doi: 10.1111/papr.12184. Epub 2014 Feb 27. Pain Pract. 2015. PMID: 24571122
DESIGN: Prospective, multicenter, observational nonrandomized patient pain registry. SETTING: Outpatient settings. PARTICIPANTS: Patients with acute episodes of noncancer pain requiring treatment with a prescription medication containing oxycodone immediate-release …
DESIGN: Prospective, multicenter, observational nonrandomized patient pain registry. SETTING: Outpatient settings. PARTICIPANTS: Patients wi …
Hippocampal volume changes after (R,S)-ketamine administration in patients with major depressive disorder and healthy volunteers.
Evans JW, Graves MC, Nugent AC, Zarate CA Jr. Evans JW, et al. Sci Rep. 2024 Feb 24;14(1):4538. doi: 10.1038/s41598-024-54370-9. Sci Rep. 2024. PMID: 38402253 Free PMC article.
Preclinical models suggest that stress-related changes in these regions can be reversed by antidepressants, including ketamine. Clinical studies have identified reduced volumes in MDD that are thought to be potentiated by early life stress and worsened by repeated depressi …
Preclinical models suggest that stress-related changes in these regions can be reversed by antidepressants, including ketamine. Clinical …
Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study.
Steigerwald I, Müller M, Davies A, Samper D, Sabatowski R, Baron R, Rozenberg S, Szczepanska-Szerej A, Gatti A, Kress HG. Steigerwald I, et al. Curr Med Res Opin. 2012 Jun;28(6):911-36. doi: 10.1185/03007995.2012.679254. Epub 2012 May 9. Curr Med Res Opin. 2012. PMID: 22443293 Clinical Trial.
OBJECTIVE: This open-label, phase 3b study evaluated the effectiveness and tolerability of tapentadol prolonged release and tapentadol immediate release (for acute pain episodes) for severe, chronic low back pain with or without a neuropathic pain component t …
OBJECTIVE: This open-label, phase 3b study evaluated the effectiveness and tolerability of tapentadol prolonged release and tapentadol immed …
22 results